Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Vanguard Mega Cap Growth ETF (MGK) Price & Performance

Heron Therapeutics IncTrade
Vanguard Mega Cap Growth ETFTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Vanguard Mega Cap Growth ETF — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Vanguard Mega Cap Growth ETF trades at $90.47. The key difference: Vanguard Mega Cap Growth ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

HRTXMGK
Market Cap
$61.47M
Sector
HealthBroad Market / Factor
52-Week High
$1.49$92.06
52-Week Low
$0.32$70.70
Enterprise Value
$168.21M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX

About Vanguard Mega Cap Growth ETF

MGK is an ETF that seeks to track the performance of the CRSP US Mega Cap Growth Index. It provides a low-cost, diversified exposure to the largest growth companies in the U.S. stock market. The fund is composed of mega-cap stocks that exhibit key growth factors, including high expected long-term earnings growth, high historical sales and earnings growth, and high return on assets. MGK is typically used by investors seeking long-term capital appreciation from market-leading firms.

Read more on MGK